Compare GKOS & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | MXL |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.4B |
| IPO Year | 2015 | 2009 |
| Metric | GKOS | MXL |
|---|---|---|
| Price | $238.12 | $48.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $243.85 | $93.64 |
| AVG Volume (30 Days) | 1.5M | ★ 3.0M |
| Earning Date | 10-28-2026 | 10-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | $478,596,000.00 |
| Revenue This Year | $53.82 | $65.58 |
| Revenue Next Year | $28.56 | $63.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $93.78 | $12.87 |
| 52 Week High | $255.19 | $128.30 |
| Indicator | GKOS | MXL |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 37.13 |
| Support Level | $147.72 | $43.00 |
| Resistance Level | $255.19 | $94.01 |
| Average True Range (ATR) | 11.84 | 5.89 |
| MACD | -1.49 | -0.24 |
| Stochastic Oscillator | 43.31 | 21.29 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.